Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

  • Showing results for a modified search because your search retrieved no results.
1.

Optimization and evaluation of desloratadine oral strip: an innovation in paediatric medication.

Singh H, Kaur M, Verma H.

ScientificWorldJournal. 2013 Oct 21;2013:395681. doi: 10.1155/2013/395681. eCollection 2013.

2.
3.

Characterization and optimization of orodispersible mosapride film formulations.

ElMeshad AN, El Hagrasy AS.

AAPS PharmSciTech. 2011 Dec;12(4):1384-92. doi: 10.1208/s12249-011-9713-z. Epub 2011 Oct 19.

4.

Safety evaluation of desloratadine in allergic rhinitis.

González-Núñez V, Valero A, Mullol J.

Expert Opin Drug Saf. 2013 May;12(3):445-53. doi: 10.1517/14740338.2013.788148. Epub 2013 Apr 11. Review.

PMID:
23574541
5.

Formulation, optimization and evaluation of levocetirizine dihyrochloride oral thin strip.

Patel JG, Modi AD.

J Pharm Bioallied Sci. 2012 Mar;4(Suppl 1):S35-6. doi: 10.4103/0975-7406.94133.

6.

The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.

Noehr-Jensen L, Damkier P, Bidstrup TB, Pedersen RS, Nielsen F, Brosen K.

Eur J Clin Pharmacol. 2006 Jun;62(6):437-45. Epub 2006 Apr 28.

PMID:
16770647
7.

Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.

Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M, Marseglia GL.

Int Immunopharmacol. 2005 Dec;5(13-14):1800-8. Epub 2005 Jun 13.

PMID:
16275616
8.

Desloratadine for allergic rhinitis.

See S.

Am Fam Physician. 2003 Nov 15;68(10):2015-6. Review. No abstract available.

9.
10.

Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.

Simons FE, Prenner BM, Finn A Jr; Desloratadine Study Group.

J Allergy Clin Immunol. 2003 Mar;111(3):617-22.

PMID:
12642846
11.

Safety of desloratadine syrup in children.

Bloom M, Staudinger H, Herron J.

Curr Med Res Opin. 2004 Dec;20(12):1959-65.

PMID:
15701213
12.

Rapid separation of desloratadine and related compounds in solid pharmaceutical formulation using gradient ion-pair chromatography.

Zheng J, Rustum AM.

J Pharm Biomed Anal. 2010 Jan 5;51(1):146-52. doi: 10.1016/j.jpba.2009.08.024. Epub 2009 Aug 26.

PMID:
19748754
13.
15.

Influence of desloratadine on selected oxidative stress markers in patients between 3 and 10 years of age with allergic perennial rhinitis.

Sadowska-Woda I, Bieszczad-Bedrejczuk E, Rachel M.

Eur J Pharmacol. 2010 Aug 25;640(1-3):197-201. doi: 10.1016/j.ejphar.2010.04.060. Epub 2010 May 21.

PMID:
20493834
16.

Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.

Ciebiada M, Ciebiada MG, Kmiecik T, DuBuske LM, Gorski P.

J Investig Allergol Clin Immunol. 2008;18(5):343-9.

17.
18.

A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.

Passalacqua G, Canonica GW.

Clin Ther. 2005 Jul;27(7):979-92. Review. Erratum in: Clin Ther. 2005 Oct;27(10):1669.

PMID:
16154477
19.

Parental attitudes toward new dosage forms of desloratadine in an online survey: results from four European countries.

Valovirta E, Scadding G.

Curr Med Res Opin. 2009 Aug;25(8):2061-7. doi: 10.1185/03007990903116834.

PMID:
19580372
20.

Effect of desloratadine on patients with allergic rhinitis and exercise-induced bronchoconstriction: a placebo controlled study.

Manjra AI, Nel H, Maharaj B.

J Asthma. 2009 Mar;46(2):156-9. doi: 10.1080/02770900802538251.

PMID:
19253122
Items per page

Supplemental Content

Write to the Help Desk